All
What Role Does MRD Play in Multiple Myeloma Treatment Decision Making?
Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.
Raising Awareness of Financial Struggles Faced by AYA Cancer Survivors
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Dive Into March 2025 FDA Approvals Across Cancer Subtypes
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal cancers.
What To Know About Having Radiation for Metastatic Prostate Cancer
As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical challenges.
First Patient Dosed With Annamycin and Cytarabine in Phase 3 AML Trial
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the global phase 3 MIRACLE trial.
Second-Line Tovecimig Elicits Responses in Biliary Tract Cancer
Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to COMPANION-002 study results.
Tagrisso May Improve Survival in Advanced EGFR-Mutant NSCLC
Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer.
Metastatic Kidney Cancer Requires a Multidisciplinary Approach to Care
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
COCOON Trial Regimen Reduces Dermatologic Side Effects in Mutated Lung Cancer
The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 trial data showed.
First-line Rybrevant Combo Extends Survival in Advanced Lung Cancer
First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.
The Positivity Trap of Follicular Lymphoma and Cancer
As a lymphoma survivor, I struggle with the positivity trap — sometimes, I just want my fears validated instead of being reassured everything is fine.
Patient With Head and Neck Cancer Dosed in Trial of APR-1051
A patient with HPV-positive head and neck squamous cell carcinoma was dosed in a phase 1 clinical trial evaluating APR-1051.
Relacorilant Plus Chemo Meets Primary Goal in Ovarian Cancer Trial
The phase 3 trial showed relacorilant with chemotherapy improved progression-free and overall survival in platinum-resistant ovarian cancer.
Inside the Mind of a Bile Duct Cancer Survivor
I’ve spent 14 years navigating recovery, mental health challenges and giving back to the cancer community through patient mentorship.
First Patient Dosed in Trial of [212Pb]VMT01 for Metastatic Melanoma
The first patient has been dosed with [212Pb]VMT01 in a phase 1/2a trial evaluating the safety of the agent in patients with melanoma.
What Patients With Kidney Cancer Need to Know From ASCO GU
There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.
Research Shines Light on Disparities Across Breast Cancer Care
Dr. Regina Hampton discusses key factors contributing to this disparity, and how healthcare systems can address these challenges.
FDA Approves Imfinzi Therapy in Muscle Invasive Bladder Cancer
The FDA approved neoadjuvant Imfinzi, gemcitabine and cisplatin, followed by adjuvant Imfinzi after radical cystectomy in muscle invasive bladder cancer.
Life Goes On, Even With Breast Cancer
I reflect on how cancer has brought out resilience and support in others, even as I struggled with my own battle, and wish others strength in their journeys.
Why Physical Therapy Should Begin at the Time of a Cancer Diagnosis
CURE spoke with Leslie Waltke about the importance of physical therapy during a cancer journey.
FDA Expands Pluvicto Indication in Prostate Cancer Subset
FDA expands Pluvicto indication to adults with PSMA+ metastatic castration-resistant prostate cancer previously treated with androgen receptor inhibitors.
SON-1010 Generates Safe Results in Advanced Sarcoma
A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or liposarcoma (LPS).
Solnerstotug Demonstrates Early Efficacy in PD-L1 Resistant Tumors
Favorable initial results from a phase 1/2 trial of solnerstotug in PD-L1–resistant tumors showed a 14% response rate and 62% disease control rate.
Childhood Cancer Survivors May Experience Sooner Aging-Related Disease
Researchers have found childhood cancer survivors are at risk of experiencing onset of aging-related disease 17.7 years sooner than the general population.
Kidney Cancer Awareness Month Highlights Advocacy and Early Detection
March is Kidney Cancer Awareness Month, highlighting the disease, early detection and and patient advocacy, with voices like Sid Sadler raising awareness.
Clinical Trial to Evaluate Opdivo, Opdualag in Glioblastoma
The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.
Quadruplet Regimen Preferable to Triplets in Multiple Myeloma
Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.
Snow, A Wig, and Memories After My Breast Cancer Diagnosis
Cancer memories often sneak up on me when I least expect them to.
CAN-2409 Elicits Survival Responses In NSCLC
Treatment with CAN-2409, an off-the-shelf immunotherapy, elicited responses among patients with pretreated stage 3/4 non–small cell lung cancer.
Itolizumab Shows Long-Term Treatment Benefits in Acute GVHD
Although itolizumab did not improve response rates at Day 29 for patients with acute GVHD, the therapy showed significant benefits in long-term outcomes.
